This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Foresta, C. Articles by Garolla, A. Search for Related Content PubMed PubMed Citation Articles by Foresta, C. Articles by Garolla, A. Related Collections Cardiovascular Endocrinology Male Endocrinology

Reduced Number of Circulating Endothelial Progenitor Cells in Hypogonadal Men

Department of Histology, Microbiology, and Medical Biotechnologies, Centre for Male Gamete Cryopreservation, University of Padova, 35121 Padova, Italy

Address all correspondence and requests for reprints to: Prof. Carlo Foresta, University of Padova, Department of Histology, Microbiology, and Medical Biotechnologies, Centre for Male Gamete Cryopreservation, Via Giustiniani 2, 35121 Padova, Italy. E-mail: carlo.foresta{at}unipd.it.

Context: Endothelial dysfunction seems to be the first step of the atherosclerotic process. In the past few years, it has been demonstrated that injured endothelial monolayer is restored by a premature pool of circulating progenitor cells (PCs) and a more mature one of circulating endothelial PCs (EPCs). Even though there is increasing evidence that estrogens play a beneficial role on EPCs and, even if debated, on the cardiovascular system, less is known about androgens.

Objective: Our objective was to evaluate the levels of circulating PCs and EPCs in men with hypogonadotropic hypogonadism (HH) and the effect of prolonged testosterone (T) replacement therapy on these cells.

Design and Setting: We conducted a prospective study on males with HH at a university andrological center.

Patients: The study included 10 young HH patients (28.6 ± 3.1 yr) and 25 age-matched controls.

Interventions: Idiopathic HH patients were treated with T gel therapy, 50 mg/d for 6 months.

Main Outcome Measures: We assessed circulating PC and EPC concentrations and immunocytochemistry for androgen receptor expression on cultured EPCs.

Results: At baseline, HH patients showed a significant reduction of both PCs and EPCs with respect to controls. T replacement therapy induced a significant increase of these cells with respect to baseline. Immunocytochemistry on cultured EPCs showed strong expression of the androgen receptor.

Conclusions: Hypotestosteronemia is associated with a low number of circulating PCs and EPCs in young HH subjects. T treatment is able to induce an increase in these cells through a possible direct effect on the bone marrow.

This article has been cited by other articles:

				A. Aversa, R. Bruzziches, D. Francomano, M. Natali, and A. Lenzi Testosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine? Therapeutic Advances in Urology, October 1, 2009; 1(4): 179 - 197. [Abstract] [PDF]

				A. M. Traish, F. Saad, R. J. Feeley, and A. Guay The Dark Side of Testosterone Deficiency: III. Cardiovascular Disease J Androl, September 1, 2009; 30(5): 477 - 494. [Abstract] [Full Text] [PDF]

				A. M. Traish Androgens Play a Pivotal Role in Maintaining Penile Tissue Architecture and Erection: A Review J Androl, July 1, 2009; 30(4): 363 - 369. [Abstract] [Full Text] [PDF]

				D. Kurbatov, J. Kuznetsky, and A. Traish Testosterone Improves Erectile Function in Hypogonadal Patients With Venous Leakage J Androl, November 1, 2008; 29(6): 630 - 637. [Abstract] [Full Text] [PDF]